Back to Companies who have applied for FDA Drug Approval

FDA Drug Approval Applications Sponsored by GE HEALTHCARE

Application NumberDrugs/ProductsApplication TypeMost Recent Label Available FlagCurrent Patent FlagAction TypeChemical TypeTher PotentialOrphan Code
008032 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
009561 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
010220 New Drug Application Approval New manufacturer (S) Standard review drug
011386 New Drug Application Approval New formulation (S) Standard review drug
013731 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
016403 New Drug Application Approval New formulation (P) Priority review drug
016847 New Drug Application Approval New ester, new salt, or other noncovalent derivative; New combination (S) Standard review drug
017042 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
017255 New Drug Application Approval New manufacturer (S) Standard review drug
017256 New Drug Application Approval New manufacturer (S) Standard review drug
017257 New Drug Application Approval New manufacturer (S) Standard review drug
017264 New Drug Application Approval New manufacturer (S) Standard review drug
017406 New Drug Application Approval New manufacturer (S) Standard review drug
017456 New Drug Application Approval New manufacturer (S) Standard review drug
017471 New Drug Application Approval New manufacturer (S) Standard review drug
017506 New Drug Application Approval New combination (S) Standard review drug
017562 New Drug Application Approval New manufacturer (S) Standard review drug
017630 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
017653 New Drug Application Approval New manufacturer (S) Standard review drug
017655 New Drug Application Approval New manufacturer (S) Standard review drug
017664 New Drug Application Approval New manufacturer (S) Standard review drug
017667 New Drug Application Approval New manufacturer (S) Standard review drug
017687 New Drug Application Approval New manufacturer (S) Standard review drug
017693 New Drug Application Approval New manufacturer (S) Standard review drug
017700 New Drug Application Approval New manufacturer (S) Standard review drug
017707 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
017773 New Drug Application Approval New manufacturer (S) Standard review drug
017775 New Drug Application Approval New manufacturer (S) Standard review drug
017784 New Drug Application Approval New manufacturer (S) Standard review drug
017838 New Drug Application Approval New manufacturer (S) Standard review drug
017848 New Drug Application Approval New formulation (S) Standard review drug
017879 New Drug Application Approval New manufacturer (S) Standard review drug
017944 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
017982 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
018088 New Drug Application Approval New ester, new salt, or other noncovalent derivative (P) Priority review drug
018110 New Drug Application Approval New manufacturer (S) Standard review drug
018141 New Drug Application Approval New manufacturer (S) Standard review drug
018289 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
018335 New Drug Application Approval New manufacturer (S) Standard review drug
018956 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
019044 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
019829 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
019862 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
020123 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
020134 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
020351 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
020372 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
020608 New Drug Application Approval New manufacturer (S) Standard review drug
020652 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
020808 New Drug Application Approval New formulation (S) Standard review drug
020899 New Drug Application Approval New formulation (S) Standard review drug
022066 New Drug Application Approval New manufacturer (S) Standard review drug
022290 New Drug Application Approval New molecular entity (NME) (P) Priority review drug (V) Orphan drug
086505 Abbreviated New Drug Application Approval
203137 New Drug Application Approval New molecular entity (NME) (S) Standard review drug

Back to Companies who have applied for FDA Drug Approval